Related Experiment Video
Updated: Jul 4, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
When to start antiretroviral therapy: a swinging pendulum?
1The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Summary
Starting antiretroviral treatment earlier offers significant benefits for patients with HIV/AIDS. Current evidence supports initiating treatment when CD4+ cell counts reach 350 cells/microL.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Early initiation of antiretroviral treatment (ART) for HIV/AIDS has shown benefits.
- Improvements in ART efficacy, tolerability, and convenience enhance treatment outcomes.
- ART reduces both HIV-related and non-HIV-related complications, irrespective of CD4+ cell count.
Purpose of the Study:
- To define the optimal timing for initiating antiretroviral therapy.
- To review current evidence supporting treatment thresholds for HIV/AIDS management.
Main Methods:
- Analysis of large patient cohort studies with extended follow-up.
- Review of clinical data on ART efficacy and complication reduction.
- Synthesis of expert recommendations on ART initiation criteria.
Main Results:
- Longer follow-up confirms the benefits of early ART initiation.
- ART initiation at a CD4+ count of 350 cells/microL is generally recommended.
- Immediate ART is indicated for specific patient groups and conditions.
Conclusions:
- Current data support initiating ART at a CD4+ threshold of 350 cells/microL.
- Early ART initiation is crucial for managing HIV/AIDS and its complications.
- Individualized treatment decisions are necessary for selected patient populations.
More Related Videos
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...